×
S&P 500   3,818.05 (-0.09%)
DOW   31,017.00 (+0.23%)
QQQ   284.11 (+0.20%)
AAPL   139.83 (+1.74%)
MSFT   260.78 (+1.68%)
META   163.74 (+1.90%)
GOOGL   2,241.41 (+0.06%)
AMZN   109.51 (+1.96%)
TSLA   675.61 (-3.21%)
NVDA   154.83 (-3.12%)
NIO   21.53 (-3.71%)
BABA   115.97 (-0.68%)
AMD   77.25 (-4.37%)
MU   55.99 (-3.23%)
CGC   3.53 (-2.22%)
T   20.77 (+0.78%)
GE   64.21 (-2.53%)
F   11.50 (-2.62%)
DIS   95.34 (-0.60%)
AMC   13.37 (-0.07%)
PFE   51.16 (+0.99%)
PYPL   71.48 (-0.47%)
NFLX   177.61 (-1.11%)
S&P 500   3,818.05 (-0.09%)
DOW   31,017.00 (+0.23%)
QQQ   284.11 (+0.20%)
AAPL   139.83 (+1.74%)
MSFT   260.78 (+1.68%)
META   163.74 (+1.90%)
GOOGL   2,241.41 (+0.06%)
AMZN   109.51 (+1.96%)
TSLA   675.61 (-3.21%)
NVDA   154.83 (-3.12%)
NIO   21.53 (-3.71%)
BABA   115.97 (-0.68%)
AMD   77.25 (-4.37%)
MU   55.99 (-3.23%)
CGC   3.53 (-2.22%)
T   20.77 (+0.78%)
GE   64.21 (-2.53%)
F   11.50 (-2.62%)
DIS   95.34 (-0.60%)
AMC   13.37 (-0.07%)
PFE   51.16 (+0.99%)
PYPL   71.48 (-0.47%)
NFLX   177.61 (-1.11%)
S&P 500   3,818.05 (-0.09%)
DOW   31,017.00 (+0.23%)
QQQ   284.11 (+0.20%)
AAPL   139.83 (+1.74%)
MSFT   260.78 (+1.68%)
META   163.74 (+1.90%)
GOOGL   2,241.41 (+0.06%)
AMZN   109.51 (+1.96%)
TSLA   675.61 (-3.21%)
NVDA   154.83 (-3.12%)
NIO   21.53 (-3.71%)
BABA   115.97 (-0.68%)
AMD   77.25 (-4.37%)
MU   55.99 (-3.23%)
CGC   3.53 (-2.22%)
T   20.77 (+0.78%)
GE   64.21 (-2.53%)
F   11.50 (-2.62%)
DIS   95.34 (-0.60%)
AMC   13.37 (-0.07%)
PFE   51.16 (+0.99%)
PYPL   71.48 (-0.47%)
NFLX   177.61 (-1.11%)
S&P 500   3,818.05 (-0.09%)
DOW   31,017.00 (+0.23%)
QQQ   284.11 (+0.20%)
AAPL   139.83 (+1.74%)
MSFT   260.78 (+1.68%)
META   163.74 (+1.90%)
GOOGL   2,241.41 (+0.06%)
AMZN   109.51 (+1.96%)
TSLA   675.61 (-3.21%)
NVDA   154.83 (-3.12%)
NIO   21.53 (-3.71%)
BABA   115.97 (-0.68%)
AMD   77.25 (-4.37%)
MU   55.99 (-3.23%)
CGC   3.53 (-2.22%)
T   20.77 (+0.78%)
GE   64.21 (-2.53%)
F   11.50 (-2.62%)
DIS   95.34 (-0.60%)
AMC   13.37 (-0.07%)
PFE   51.16 (+0.99%)
PYPL   71.48 (-0.47%)
NFLX   177.61 (-1.11%)
NASDAQ:CNMD

CONMED Stock Forecast, Price & News

$99.56
+2.07 (+2.12%)
(As of 06/29/2022 11:49 AM ET)
Add
Compare
Today's Range
$96.93
$99.76
50-Day Range
$88.23
$154.18
52-Week Range
$87.24
$159.11
Volume
14,989 shs
Average Volume
352,297 shs
Market Capitalization
$2.94 billion
P/E Ratio
47.41
Dividend Yield
0.82%
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

CNMD Stock Forecast (MarketRank)

Overall MarketRank

0.71 out of 5 stars

Medical Sector

1319th out of 1,433 stocks

Electromedical Equipment Industry

29th out of 30 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
CONMED logo

About CONMED (NASDAQ:CNMD)

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

CNMD Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CNMD
Employees
3,800
Year Founded
N/A

Company Calendar

Last Earnings
5/04/2022
Today
6/29/2022
Fiscal Year End
12/31/2022

Profitability

Net Income
$62.54 million
Pretax Margin
7.92%

Debt

Sales & Book Value

Annual Sales
$1.01 billion
Cash Flow
$6.66 per share
Book Value
$26.85 per share

Miscellaneous

Free Float
28,079,000
Market Cap
$2.94 billion
Optionable
Optionable
Beta
1.52














CONMED Frequently Asked Questions

How has CONMED's stock performed in 2022?

CONMED's stock was trading at $148.55 at the beginning of the year. Since then, CNMD shares have decreased by 33.5% and is now trading at $98.85.
View the best growth stocks for 2022 here
.

How were CONMED's earnings last quarter?

CONMED Co. (NASDAQ:CNMD) issued its quarterly earnings data on Wednesday, May, 4th. The company reported $0.70 earnings per share for the quarter, topping analysts' consensus estimates of $0.62 by $0.08. The business had revenue of $242.33 million for the quarter, compared to the consensus estimate of $235.55 million. CONMED had a net margin of 6.63% and a trailing twelve-month return on equity of 13.27%.
View CONMED's earnings history
.

Is CONMED a good dividend stock?

CONMED(NASDAQ:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.82%. The dividend payout ratio of CONMED is 38.10%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CONMED will have a dividend payout ratio of 19.80% next year. This indicates that CONMED will be able to sustain or increase its dividend.

Who are CONMED's key executives?

CONMED's management team includes the following people:
  • Mr. Curt R. Hartman, Chairman, CEO & Pres (Age 58, Pay $2M)
  • Mr. Todd W. Garner, Exec. VP & CFO (Age 53, Pay $908.45k)
  • Mr. Daniel S. Jonas Esq., Exec. VP of Legal Affairs, Gen. Counsel & Sec. (Age 58, Pay $646.48k)
  • Mr. Stanley W. Peters III, Pres of Advanced Surgical & Advanced Endoscopic Technologies (Age 47, Pay $681.04k)
  • Mr. Patrick J. Beyer, Pres of International & Global Orthopedics (Age 56, Pay $1.24M)
  • Mr. Peter K. Shagory, Exec. VP of Strategy & Corp. Devel. (Age 53)
  • Ms. Heather L. Cohen, Exec. VP of HR (Age 49)
  • Mr. John E. Kennedy, Special Advisor (Age 64)
  • Ms. Shanna L. Cotti-Osmanski, Exec. VP of Information Technology & CIO (Age 45)
  • Mr. David R. Murray, Pres of ConMed Electrosurgery (Age 74)

What other stocks do shareholders of CONMED own?

What is CONMED's stock symbol?

CONMED trades on the NASDAQ under the ticker symbol "CNMD."

How do I buy shares of CONMED?

Shares of CNMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CONMED's stock price today?

One share of CNMD stock can currently be purchased for approximately $98.85.

How much money does CONMED make?

CONMED (NASDAQ:CNMD) has a market capitalization of $2.92 billion and generates $1.01 billion in revenue each year. The company earns $62.54 million in net income (profit) each year or $2.10 on an earnings per share basis.

How many employees does CONMED have?

CONMED employs 3,800 workers across the globe.

How can I contact CONMED?

CONMED's mailing address is 11311 CONCEPT BOULEVARD, LARGO FL, 33773. The official website for CONMED is www.conmed.com. The company can be reached via phone at 727 392 6464 or via fax at 315-797-0321.

This page (NASDAQ:CNMD) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.